WASHINGTON, Aug. 1 (TNSFR) -- The U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), Office of Pharmacy Affairs (OPA), which administers the 340B Drug Pricing Program, is issuing this Notice to announce the availability of a revised 340B Rebate Model Pilot Program. The Pilot provides a rebate mechanism through which qualifying drug manufacturers may effectuate the 340B ceiling price for certain drugs sold to covered entities. Consistent with . . .

Click here for more information about our products